Send to:

Choose Destination
See comment in PubMed Commons below
Trends Immunol. 2001 Aug;22(8):424-7.

Antinuclear autoantibodies as potential antineoplastic agents.

Author information

  • 1Dept of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, 360 Huntington Ave., Boston, MA 02115, USA.


The immune system confines neoplasia at various stages of tumor development. Whereas the role of cellular immunity has been investigated widely and utilized in the clinic, the importance of humoral immunity in this process has begun to emerge only in recent years. Circulating antinuclear autoantibodies (ANAs) typically found in autoimmune conditions, have also been detected in cancer patients and in healthy elderly individuals. The pathogenic role of ANAs in autoimmunity is well studied; however, little research has been carried out to elucidate the functions of ANAs in cancer patients. Experimental data favoring the antitumor activity of ANAs might support the clinical testing of monoclonal ANAs as a cancer therapy, if confirmed by further experiments.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk